RhumbLine Advisers
JBIO

RhumbLine Advisers’s Jade Biosciences JBIO Stock Holding History

RhumbLine Advisers’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$570K Sell
40,551
-9,502
-19% -$138K ﹤0.01% 2531
2025
Q4 		$772K Buy
50,053
+7,269
+17% +$85.3K ﹤0.01% 2373
2025
Q3 		$369K Sell
42,784
-1,786
-4% -$14.6K ﹤0.01% 2880
2025
Q2 		$445K Buy
44,570
+43,920
+6,757% +$1.49M ﹤0.01% 2755
2025
Q1 		$57.1K Buy
650
+262
+68% +$23K ﹤0.01% 3540
2024
Q4 		$36K Buy
388
+9
+2% +$776 ﹤0.01% 3721
2024
Q3 		$27.7K Sell
379
-52
-12% -$3.35K ﹤0.01% 3772
2024
Q2 		$25K Buy
431
+13
+3% +$8.62K ﹤0.01% 3832
2024
Q1 		$432K Buy
418
+14
+3% +$10.7K ﹤0.01% 2756
2023
Q4 		$320K Buy
404
+4
+1% +$2.04K ﹤0.01% 2929
2023
Q3 		$190K Buy
400
+29
+8% +$15.7K ﹤0.01% 3187
2023
Q2 		$223K Sell
371
-52
-12% -$33.3K ﹤0.01% 3186
2023
Q1 		$298K Buy
423
+16
+4% +$13.3K ﹤0.01% 2617
2022
Q4 		$417K Buy
407
+3
+0.7% +$2.18K ﹤0.01% 2554
2022
Q3 		$234K Buy
404
+27
+7% +$18K ﹤0.01% 2838
2022
Q2 		$206K Buy
+377
New +$180K ﹤0.01% 2916

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return